Studies of respiratory function in volunteers given live influenza virus vaccine
- PMID: 604095
Studies of respiratory function in volunteers given live influenza virus vaccine
Abstract
Measurements of peak flow, vital capacity, FEV1 and flow volume studies were performed in healthy volunteers for 20 weeks following intranasal vaccination with live-attenuated A/Victoria/3/75 recombinants or placebo. Despite differing attenuation of the two candidate strains, no effect on pulmonary function was detected.
Similar articles
-
A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.Dev Biol Stand. 1976;33:202-6. Dev Biol Stand. 1976. PMID: 782970 Clinical Trial.
-
Attenuated influenza virus in normal adults: role of pulmonary function studies in vaccine trials.J Infect Dis. 1976 Feb;133(2):145-52. J Infect Dis. 1976. PMID: 1245763
-
Properties of A/Victoria/3/75 recombinants: development of an attenuated strain RIT 4050.Dev Biol Stand. 1977 Jun 1-3;39:43-6. Dev Biol Stand. 1977. PMID: 604127
-
Live influenza vaccine in patients with chronic bronchopulmonary diseases. A multicenter study with two consecutive vaccinal strains.Dev Biol Stand. 1977 Jun 1-3;39:113-21. Dev Biol Stand. 1977. PMID: 604093
-
Live attenuated influenza vaccine in children.Semin Pediatr Infect Dis. 2006 Oct;17(4):206-12. doi: 10.1053/j.spid.2006.08.007. Semin Pediatr Infect Dis. 2006. PMID: 17055372 Review.
Cited by
-
Protection from natural infection after live influenza virus immunization in an open population.J Hyg (Lond). 1979 Apr;82(2):231-6. doi: 10.1017/s002217240002564x. J Hyg (Lond). 1979. PMID: 429787 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical